Cyclooxygenase-2 and gastric carcinogenesis - Wikidata - thesis-toulmin - TriplyDB

Cyclooxygenase-2 and gastric carcinogenesis

Cyclooxygenase-2 and gastric carcinogenesis

http://www.wikidata.org/entity/Q28184447

about

Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways Gastric Cancer: How Can We Reduce the Incidence of this Disease?Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells.Microvessel density is a prognostic marker of human gastric cancer.Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells.Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling.Prevention and management of duodenal polyps in familial adenomatous polyposis.Tissue-specific promoters for cancer gene therapy.Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling Heterotopic Gastric Mucosa in the Distal Part of Esophagus in a Teenager: Case Report.Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.Cyclooxygenase-2 in cancer and angiogenesis.Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression.Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells Expression of Cyclooxygenase-2 and Bcl-2 in human gastric adenomas.From inflammation to gastric cancer: Role of Helicobacter pylori.Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development.Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.Cyclooxygenase-2 and gastric cancer.The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models.Role of cyclooxygenase-2 in gastric cancer development and progression.Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways.NNK enhances cell migration through α7-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer.Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo.Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells.Lactobacillus acidophilus 74-2 and butyrate induce cyclooxygenase (COX)-1 expression in gastric cancer cells.Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.Heregulin-alpha and heregulin-beta expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts.Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.Over-expression of cyclooxygenase-2 in endoscopic biopsies of ectopic gastric mucosa.Chemoprevention by celecoxib in reflux-induced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy.Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions.Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.

P2860

Q26748123-BDD05DF7-0E01-46CB-976E-7BC6435E8845 Q26749352-5F413536-049E-42D6-B8A5-79ABEA8798D6 Q28303196-F24EB834-F609-41B1-AE9C-ADDAE32D6549 Q33313240-26FECAAE-89D1-4776-9A26-EDFB3DE586FE Q33664095-B434C52D-9D8B-4CCE-A6B4-FFC772E6E054 Q33747725-6C48626E-FC2C-4617-A093-C5281328D29F Q33868722-3F67A0E9-8204-41B9-84AE-BB56C37A8D60 Q33873644-9B6FB612-73A6-4372-9FC2-3259DDBA1D20 Q35131505-B4C14F62-0F9C-4089-80DE-6A7D4B485432 Q35597651-5CB6DDE1-0BAA-4C45-AC20-D2E832ADF6DF Q35779378-AAA996A5-6A23-43BC-BEEB-7356A3ECC00D Q36205479-5F9BAA9D-0850-4A1B-83D9-D9873628EE55 Q36206912-068E327F-9221-4F72-A06C-0E36CC457A0F Q36380799-14C39B06-3FA2-4E42-801A-19A4AFDA783D Q37174279-61903AB0-78F1-44AD-BB8D-FD4F16FCB019 Q37226245-7D4D3187-2F4E-4494-97E3-119C6325EBA1 Q37437607-8496BD4B-29D6-4742-845C-98C92F906394 Q37454439-4050616A-06C4-4C6B-A8AE-C5510A4EA459 Q37476188-9936FC64-FC4A-4F09-99AA-0ADA253BB07C Q37701082-F2780C0B-9986-4C38-9319-D5E07AFB68B8 Q37725907-331BBCFD-C179-4B0A-9E18-40EA330F87D9 Q37746347-79EFA4DB-3B99-4F93-ADEF-BCA0527D3A1D Q37946290-8D11A49F-1410-4F30-A2FD-F34DD200D4EC Q37973270-46E7AD65-A4CB-4C5B-9F89-5D4E797DE8BA Q38164703-FFAE0077-1DAB-4224-ACAB-403C8274A9E4 Q38338269-5022AE76-F464-4FE8-9968-744225EDB854 Q39142094-C705892D-EA94-4CBB-980D-A3348F201161 Q39463677-5ACE2EB7-1AC5-4A92-BAF7-6E9D30CC646B Q39487878-758D5BBB-975D-442E-8DA4-213DE6A745B6 Q39772800-223D425B-2D43-468B-9947-CF39206EF38C Q39942512-C4547F71-7567-4E78-B09D-FB619F6808AE Q39962684-3475BDD8-5054-45F9-AB73-60F2C70C05C6 Q40337325-62E5A87A-F689-490E-9DF0-38D7CD615DFB Q40339674-0B07C542-1223-426F-867B-9BB389D6B499 Q40961127-CA456298-817A-4130-A8AE-38219AFECC60 Q43879599-2B64EDD6-EA64-473E-A420-025D9B4176AE Q45979168-57AD09AE-66A5-4377-BA83-19C66E97798E Q46582619-C57280CF-BF51-4107-91E3-35257E552FC3 Q50129416-B65F4DBB-2F6A-4F2A-8563-A37687FF7162 Q51772676-45A44238-32D2-460E-B7D3-BA682E5E246D

P2860

Cyclooxygenase-2 and gastric carcinogenesis

http://www.wikidata.org/entity/Q28184447

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Cyclooxygenase-2 and gastric carcinogenesis

@ast

Cyclooxygenase-2 and gastric carcinogenesis

@en

Cyclooxygenase-2 and gastric carcinogenesis

@nl

type

label

Cyclooxygenase-2 and gastric carcinogenesis

@ast

Cyclooxygenase-2 and gastric carcinogenesis

@en

Cyclooxygenase-2 and gastric carcinogenesis

@nl

prefLabel

Cyclooxygenase-2 and gastric carcinogenesis

@ast

Cyclooxygenase-2 and gastric carcinogenesis

@en

Cyclooxygenase-2 and gastric carcinogenesis

@nl

P1433

Q28184447-E7015C19-B7F7-4B8E-8781-4E6F86AB6976

P1476

Q28184447-0F50F662-D77A-4634-AFD8-604A86C4718D

P2093

Q28184447-13A6098F-5939-42F9-9C52-D69DAC267E1C

Q28184447-2BEBD798-6FAF-4C26-A184-8725E9E8E3AD

Q28184447-2DF29439-9E55-4EC3-BFD7-CD33C73B44AB

Q28184447-6FAFD942-1036-4CAA-903F-26295380775A

Q28184447-8545E775-120E-4513-B518-769D8852096C

Q28184447-A84B15A1-DE5E-4754-8062-0EC45BFF77E3

Q28184447-AD434D6E-5D77-4628-88E6-9A79FF582023

Q28184447-C6E61679-E51D-4384-962A-0817855C151F

Q28184447-F9E5CF95-5F69-40FA-81FF-750F8D6F018A

Q28184447-FCDF4453-793D-4092-BD38-DE03655E7C62

P2860

Q28184447-0E6A001E-1053-4788-A4E1-E27D4DF21D51

Q28184447-1D286CFF-3E4C-449D-8900-A8367D62EED0

Q28184447-29209DFC-70BB-4136-A283-7DBAD380E31C

Q28184447-2AEA9A78-F499-4F72-B43B-65E24B9B8819

Q28184447-2B19CD85-1B9F-4A7F-A3AD-FC2CD8D2269A

Q28184447-2CE1E512-41E2-4D36-AA59-3EC1CAA6BC28

Q28184447-2F428B0C-FE48-4FF6-942C-92BA7D4F8A82

Q28184447-33ABAACB-CE85-4086-92EF-BD2B0B130DE9

Q28184447-48011053-1DDB-4576-9989-4471372E5F50

Q28184447-4EECAD29-DC09-4000-AA96-B1C61BA2F639

P304

Q28184447-92EC91DB-2EF2-452C-9847-7AE1B0A37929

P31

Q28184447-D8B9124B-327C-4031-AFD6-BCFC139F3F4C

P3181

Q28184447-F3AAC344-EC38-4791-84EB-1AC704B4C0FA

P356

Q28184447-34998647-ABB5-42C1-8AA3-A38E28DED601

P407

Q28184447-C4A83588-7B52-47EC-966B-EB790ED2AFC0

P433

Q28184447-1726844A-340C-4E79-9007-C96906D783E0

P478

Q28184447-DD254FD6-CCA8-40DD-A077-CCE54FA2E74B

P577

Q28184447-AE3B57F1-15B4-4079-85CC-5FD856DB45C8

P698

Q28184447-C4914138-8551-4A83-80C7-84D94197E7B1

P3181

P356

J.1600-0463.2003.1111001.X

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

Cyclooxygenase-2 and gastric carcinogenesis

@en

P2093

Anna Sivula

http://www.w3.org/2001/XMLSchema#string

Ari Ristimaki

http://www.w3.org/2001/XMLSchema#string

Bastiaan P Van Rees

http://www.w3.org/2001/XMLSchema#string

Caj Haglund

http://www.w3.org/2001/XMLSchema#string

Christianne J Buskens

http://www.w3.org/2001/XMLSchema#string

G Johan A Offerhaus

http://www.w3.org/2001/XMLSchema#string

J Jan B Van Lanschot

http://www.w3.org/2001/XMLSchema#string

Johanna Rintahaka

http://www.w3.org/2001/XMLSchema#string

Kirsi Saukkonen

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Rio

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

Cyclooxygenases 1 and 2

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

Molecular epidemiology, pathogenesis and prevention of gastric cancer.

P304

915-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

289295

http://www.w3.org/2001/XMLSchema#string

P356

10.1034/J.1600-0463.2003.1111001.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14616542

http://www.w3.org/2001/XMLSchema#string